Sanctuary Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.97M Sell
69,677
-23,718
-25% -$1.29M 0.01% 835
2026
Q1
$5.86M Sell
93,395
-347
-0.4% -$27.8K 0.03% 512
2025
Q4
$8.94M Buy
93,742
+7,133
+8% +$699K 0.05% 382
2025
Q3
$8.46M Buy
86,609
+10,602
+14% +$1.1M 0.05% 385
2025
Q2
$8.16M Buy
76,007
+9,192
+14% +$930K 0.05% 372
2025
Q1
$6.74M Sell
66,815
-127
-0.2% -$12.8K 0.05% 396
2024
Q4
$6.9M Sell
66,942
-93
-0.1% -$8.19K 0.04% 407
2024
Q3
$6.03M Sell
67,035
-6,069
-8% -$478K 0.04% 449
2024
Q2
$5.35M Buy
+73,104
New +$5.35M 0.04% 434

Other funds holding BSX

Sanctuary Advisors's BSX Position: Q2 2026 in Review

Sanctuary Advisors reduced its Boston Scientific (BSX) stake by 25% in Q2 2026, selling an estimated $1.29M and leaving 69,677 shares worth $2.97M. The position accounts for 0.01% of the portfolio, ranked #835.

Sanctuary Advisors first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.94M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Sanctuary Advisors held 69,677 shares of Boston Scientific worth $2.97M as of Q2 2026.
  • Sanctuary Advisors sold 23,718 Boston Scientific shares in Q2 2026, an estimated $1.29M.
  • Boston Scientific made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #835 holding.
  • Sanctuary Advisors first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Boston Scientific position peaked at $8.94M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.